血液形成衰老通过促进IL-1驱动的紧急骨髓形成促进癌症
Matthew D Park1,2,3, Jessica Le Berichel1,2,3, Pauline Hamon1,2,3
1Department of Immunology and Immunotherapy, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
概括
衰老的免疫系统通过增加产生互白素-1α (IL-1) 的骨髓细胞来加速癌症的进展. 准这种途径会减缓瘤的生长速度,
科学领域:
- 免疫学
- 癌症学
- 老龄化研究
背景情况:
- 年龄是癌症的重要危险因素.
- 老龄化影响瘤控制的确切机制尚未完全理解.
- 免疫系统在癌症进展中的作用需要进一步阐明.
研究的目的:
- 研究免疫系统老化如何影响肺癌的进展.
- 确定推动年龄相关癌症生长的细胞和分子机制.
- 探索针对与年龄有关的癌症机制的潜在治疗策略.
主要方法:
- 研究了造血衰老对小鼠肺部瘤发展的影响.
- 分析了骨髓样细胞和IL-1α在瘤进展中的作用.
- 研究了DNA甲基转移酶3A (DNMT3A) 在IL-1产生中的功能.
- 评估了破坏IL-1受体1 (IL-1R1) 信号对多种癌症类型瘤生长的影响.
- 检查人类瘤样本以检查与年龄相关的免疫细胞透和预后意义.
主要成果:
- 血液形成的衰老, 独立于结构或瘤的年龄, 驱动肺癌的进展.
- 通过免疫衰老增强了产生IL-1的骨髓原细胞的积累.
- 与年龄相关的DNMT3A下降会增加IL-1的产生.
- 早期破坏IL-1R1信号正常化骨髓形成,抑制肺,结肠和胰腺瘤的生长.
- 人类瘤显示IL-1表达单细胞衍生的巨细胞与年龄较大,存活率较低和复发相关.
结论:
- 免疫系统衰老是癌症发展的关键因素.
- IL-1/IL-1R1轴代表着衰老促进瘤发生的关键途径.
- 针对IL-1R1信号提供了与年龄相关的癌症的有希望的治疗策略.
- 了解与年龄相关的免疫变化为癌症治疗和预防提供了可行的见解.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K
Overview of Hematopoiesis
3.9K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
3.9K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Role of Hematopoietic Growth Factors
1.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


